If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Regulatory News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
72.50    0.50 (0.69%)
Bid:
72.00
Ask:
73.00
Spread: 1.00 (1.389%)
Market Cap: £342.04m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Board Appointment

23 Dec 2013 07:00

RNS Number : 1772W
Avacta Group PLC
23 December 2013
 



 

 

 

Avacta Group plc

("Avacta" or the "Group")

 

Craig Slater joins the Board of Avacta Group plc as Chief Operating Officer

 

Avacta Group plc, the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, is pleased to announce that Craig Slater has joined the Board as Chief Operating Officer with immediate effect.

 

Mr Slater has more than 25 years experience of commercial, operational and group management roles in specialist engineering, construction, software and marketing groups. More specifically this experience includes the supply of specialist equipment to Life Science clients, B2B service provision and the implementation of growth plans in SME businesses. Mr Slater has been working with Avacta since June 2012, primarily in a commercial and operational capacity within Avacta Analytical and latterly within Avacta Animal Health.

 

Commenting on the appointment, Alastair Smith, Chief Executive of Avacta said: "The Board is delighted that Craig is joining the Group as Chief Operating Officer. We have already benefited greatly from his experience since he joined us in 2012 and his operational and strategic input will be invaluable in the future."

 

Mr Slater, aged 50, is a director/partner or has been a director/partner of the following companies/partnerships during the previous five years:

 

Current Directorships

Veracito Limited

QPC Holdings Limited

Adapt Formwork Holdings Limited

Adapt Formwork Limited

Gateway 3D Limited

Sitedesk Limited

 

Previous Directorships (in last 5 years)

Eleco Public Limited Company

Bell & Webster Concrete Limited

Milbury Systems Limited

Eleco (Pp) Limited

Eleco (Dcs) Limited

Eleco (Spp) Limited

Eleco (Gns) Limited

Eleco (Sd) Limited

CORGI Group Limited

Corgi Gas Registration Limited

Corgi Services Limited

Altitude Group Plc

Adproducts.com Limited

Advertising Gifts Limited

Advertising Gifts.net Limited

Boxcam Limited

Brand Logistics Limited

Business Gifts Limited

Corporate Gifts Limited

Corporate Solutions (UK) Limited

Distinctive Ideas Limited

Dowlis Corporate Solutions (UK) Limited

Promoserve Business Systems Limited

Promotional Gifts Limited

Promotional Items Limited

Promotional Merchandise Limited

Promotional Store Limited

Ross Promotional Products Limited

Silent Kite Limited

The Advertising Products Group Limited

The Bentley Collection Limited

Touchpaper Communications Limited

Trade Only Limited

 

Mr Slater does not hold any ordinary shares, or options over ordinary shares, in the Company.

 

Save for the information disclosed above there is no other information to be disclosed on Mr Slater under Schedule 2(g) of the AIM Rules.

 

- Ends -

 

Enquiries:

 

Avacta Group plc

www.avacta.com

Alastair Smith, Chief Executive Officer

Tel: +44 (0) 844 414 0452

Tim Sykes, Chief Financial Officer

 

 

 

Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

 

James Black (Corporate Broking)

 

 

 

Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780 or avacta@walbrookpr.com

Mike Wort

Mob: +44 (0)7900 608 002

Lianne Cawthorne

Mob: +44 (0)7584 391 303

 

 

About Avacta Group plc - www.avacta.com

 

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:

 

Avacta Analytical

www.avactaanalytical.com

 

High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development.

Avacta Animal Health

www.avactaanimalhealth.com

 

Veterinary diagnostics reference laboratory, diagnostic kits and newly launched in-clinic blood analyser, Sensipod.

Avacta Life Sciences

www.avactalifesciences.com

 

Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development.

 

Avacta joined AIM in August 2006 and is based in Wetherby, England.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFEWFFFFDSELE
Date   Source Headline
16th Aug 20167:00 amRNSNew Facilities in Cambridge and Wetherby
10th Aug 20167:00 amRNSGrant Funding
3rd Aug 20167:00 amRNSKey Affimer patents to be granted in Europe and US
1st Aug 20167:00 amRNSTrading Statement
19th Jul 20163:13 pmRNSHolding(s) in Company
19th Jul 20167:15 amRNSHardman report: New Affimer opportunities
14th Jul 20167:00 amRNSCollaboration with Glythera
8th Jul 20167:00 amRNSDirector/PDMR Shareholding
22nd Jun 20167:00 amRNSAffimer Binders for Zika Virus Diagnostics
16th Jun 201611:08 amRNSIssue of Equity
13th Jun 20167:00 amRNSCollaboration with Mologic
29th Apr 20163:04 pmRNSDirector's Dealing
25th Apr 20167:00 amRNSHalf-year Report
19th Apr 20167:00 amRNSAffimer Therapeutic Platform Development Milestone
7th Apr 20167:00 amRNSDirector's Dealing
5th Apr 20167:00 amRNSInvestor Evening
15th Mar 20167:00 amRNSIssue of Equity
7th Mar 20167:00 amRNSAvacta Establishes Scientific Advisory Board
25th Feb 20164:34 pmRNSHolding(s) in Company
24th Feb 20167:00 amRNSGrant Funding Awarded
23rd Feb 201610:54 amRNSHardman & Co Issues Research Report
23rd Feb 20167:00 amRNSDirector's Dealing
17th Feb 20167:00 amRNSDirectors' Dealings and Issue of Equity
26th Jan 20168:05 amRNSShare Consolidation
25th Jan 20163:35 pmRNSResult of Annual General Meeting
25th Jan 20167:01 amRNSPre-close trading update
25th Jan 20167:00 amRNSPhilippe Cotrel Appointed Chief Commercial Officer
21st Jan 20167:00 amRNSProposed Shareholder Consolidation
7th Jan 20167:00 amRNSPosting of Annual Report & Accounts and AGM Notice
5th Jan 20167:00 amRNSIssue of Equity
10th Dec 20157:00 amRNSAppointment of Tony Gardiner as CFO
1st Dec 20154:44 pmRNSHolding(s) in Company
30th Nov 20157:00 amRNSIssue of Equity
23rd Nov 20157:00 amRNSIssue of Equity
6th Nov 201510:56 amRNSHolding(s) in Company
30th Oct 20157:00 amRNSIssue of Equity
26th Oct 20157:00 amRNSFinal Results
19th Oct 20157:00 amRNSAffimers improve disease resistance in plants
9th Oct 20157:00 amRNSRobust performance of Affimers on Luminex platform
8th Oct 20157:00 amRNSNotice of Results
17th Sep 20157:00 amRNSAppoints Dr Mike Owen as Non-executive Director
10th Sep 20157:00 amRNSTotal Voting Rights
3rd Sep 20157:00 amRNSIssue of Equity
5th Aug 201510:00 amRNSHolding(s) in Company
5th Aug 20157:00 amRNSHolding(s) in Company
4th Aug 201510:18 amRNSIssue of Equity
31st Jul 201510:42 amRNSResult of General Meeting
23rd Jul 20157:00 amRNSIssue of Equity
15th Jul 20157:00 amRNSConditional Placing to Raise up to £22.0 Million
7th Jul 20158:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.